The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALLERGAN PLC | SHS | G0177J108 | 46,491 | 194,589 | SH | SOLE | 194,589 | 0 | 0 | ||
ALPHABET INC | CAP STK CL C | 02079K107 | 55,332 | 66,700 | SH | SOLE | 66,700 | 0 | 0 | ||
ASHLAND GLOBAL HLDGS INC | COM | 044186104 | 55,890 | 451,417 | SH | SOLE | 451,417 | 0 | 0 | ||
ATHENE HLDG LTD | CL A | G0684D107 | 25,820 | 516,508 | SH | SOLE | 516,508 | 0 | 0 | ||
CADENCE DESIGN SYSTEM INC | COM | 127387108 | 231,075 | 7,359,071 | SH | SOLE | 7,359,071 | 0 | 0 | ||
GCP APPLIED TECHNOLOGIES INC | COM | 36164Y101 | 158,496 | 4,854,386 | SH | SOLE | 4,854,386 | 0 | 0 | ||
GRACE W R & CO DEL NEW | COM | 38388F108 | 2,092 | 30,010 | SH | SOLE | 30,010 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 18,217 | 399,496 | SH | SOLE | 399,496 | 0 | 0 | ||
PTC INC | COM | 69370C100 | 44,930 | 855,000 | SH | SOLE | 855,000 | 0 | 0 | ||
SHERWIN WILLIAMS CO | COM | 824348106 | 25,436 | 82,000 | SH | SOLE | 82,000 | 0 | 0 | ||
UNITED TECHNOLOGIES CORP | COM | 913017109 | 32,316 | 288,000 | SH | SOLE | 288,000 | 0 | 0 | ||
VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 7,870 | 713,550 | SH | SOLE | 713,550 | 0 | 0 | ||
VISA INC | COM CL A | 92826C839 | 24,439 | 275,000 | SH | SOLE | 275,000 | 0 | 0 |